Montelukast is a member of quinolines, a monocarboxylic acid and an aliphatic sulfide. Among its listed roles, it functions as a leukotriene antagonist, an anti-asthmatic drug and an anti-arrhythmia drug. It is the conjugate acid of montelukast(1-). It is grouped under the following drug class(es): Leukotriene modifiers. Its therapeutic use is listed as anti-asthmatic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Brondilat, Singulair and Aerokast. Its PubChem CID is 5281040.
Montelukast
| CAS No | 158966-92-8 |
|---|---|
| Molecular Formula | C35H36ClNO3S |
| Molecular Weight | 586.20 g/mol |
| Synonyms | 2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Montelukast is a member of quinolines, a monocarboxylic acid and an aliphatic sulfide. Among its listed roles, it functions as a leukotriene antagonist, an anti-asthmatic drug and an anti-arrhythmia drug.
The listed CAS number is 158966-92-8.
The listed molecular formula is C35H36ClNO3S.
The listed molecular weight is 586.20 g/mol.
2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid.
The source lists Brondilat, Singulair and Aerokast.